T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIME
1851
DELISTED
Mimecast Limited
MIME
| $1.4M | ﹤0.01% |
17,538
-2,862
| -14% | -$216K |
|
1852
Compass Minerals
CMP
$1.1B
| $1.39M | ﹤0.01% |
27,266
-1,383
| -5% | -$84.3K |
|
1853
White Mountains Insurance
WTM
$5.11B
| $1.39M | ﹤0.01% |
1,373
-53
| -4% | -$56K |
|
1854
Celsius Holdings
CELH
$7.28B
| $1.39M | ﹤0.01% |
55,704
-9,660
| -15% | -$267K |
|
1855
Tanger
SKT
$4.42B
| $1.38M | ﹤0.01% |
71,464
-9,521
| -12% | -$181K |
|
1856
Liberty Global Class A
LBTYA
$3.6B
| $1.38M | ﹤0.01% |
49,629
+200
| +0.4% | +$5.69K |
|
1857
Nicolet Bankshares
NIC
$3.75B
| $1.37M | ﹤0.01% |
16,022
+2,377
| +17% | +$181K |
|
1858
Moelis & Co
MC
$5.05B
| $1.37M | ﹤0.01% |
21,949
-1,590
| -7% | -$107K |
|
|
BBBY
1859
Bed Bath & Beyond
BBBY
$419M
| $1.37M | ﹤0.01% |
25,557
+270
| +1% | +$20.4K |
|
1860
Opko Health
OPK
$993M
| $1.37M | ﹤0.01% |
284,674
| – | – |
|
|
GCP
1861
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.37M | ﹤0.01% |
43,137
-808
| -2% | -$20.6K |
|
1862
VEON
VEON
$3.94B
| $1.36M | ﹤0.01% |
31,928
| – | – |
|
|
LTHM
1863
DELISTED
Livent Corporation
LTHM
| $1.36M | ﹤0.01% |
55,886
-4,131
| -7% | -$112K |
|
1864
Bread Financial
BFH
$4.57B
| $1.36M | ﹤0.01% |
20,451
-6,725
| -25% | -$497K |
|
1865
CareTrust REIT
CTRE
$9.25B
| $1.36M | ﹤0.01% |
59,547
-1,710
| -3% | -$36.2K |
|
|
ALE
1866
DELISTED
Allete
ALE
| $1.35M | ﹤0.01% |
20,359
-1,187
| -6% | -$74.4K |
|
1867
e.l.f. Beauty
ELF
$5.49B
| $1.35M | ﹤0.01% |
40,552
-5,239
| -11% | -$162K |
|
1868
Outfront Media
OUT
$5.32B
| $1.35M | ﹤0.01% |
51,020
-10,674
| -17% | -$275K |
|
1869
Tenable Holdings
TENB
$4.26B
| $1.35M | ﹤0.01% |
24,454
-1,373
| -5% | -$71.1K |
|
|
BIG
1870
DELISTED
Big Lots, Inc.
BIG
| $1.34M | ﹤0.01% |
29,822
-688
| -2% | -$31.3K |
|
1871
Boot Barn
BOOT
$4.94B
| $1.34M | ﹤0.01% |
10,892
+1,817
| +20% | +$205K |
|
1872
Community Bank
CBU
$3.47B
| $1.34M | ﹤0.01% |
17,971
-932
| -5% | -$67.9K |
|
|
CSLT
1873
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.33M | ﹤0.01% |
866,703
-2,400
| -0.3% | -$3.96K |
|
1874
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.33M | ﹤0.01% |
23,565
-750
| -3% | -$41.7K |
|
|
UCB
1875
United Community Banks
UCB
$4.43B
| $1.33M | ﹤0.01% |
37,062
-2,432
| -6% | -$85K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.